Acknowledgements
We would like to thank Mariann Lassenius and Iiro Toppila, Medaffcon for
their significant contribution in the study design. We would also like
to thank Josefine Persson, AstraZeneca for her valuable input to the
study design and reviewing of the manuscript.
Authorship: STS, KN, GT, LL contributed to study design. All
authors STS, JA, BM, JH, KN, GT and LL contributed to interpretation of
data and were involved in manuscript writing and revision. JA and JH
contributed to data acquisition and analyses. All authors STS, JA, BM,
JH, KN, GT and LL gave final approval for manuscript publication and
agreed to be accountable for all aspects of their work.
The study was funded by
AstraZeneca Nordic, Sweden.